Abstract
Background
Deep brain stimulation (DBS) programming of multicontact DBS leads relies on a very time-consuming manual screening procedure, and strategies to speed up this process are needed. Beta activity in subthalamic nucleus (STN) local field potentials (LFP) has been suggested as a promising marker to index optimal stimulation contacts in patients with Parkinson disease.
Objective
In this study, we investigate the advantage of algorithmic selection and combination of multiple resting and movement state features from STN LFPs and imaging markers to predict three relevant clinical DBS parameters (clinical efficacy, therapeutic window, side-effect threshold).
Materials and Methods
STN LFPs were recorded at rest and during voluntary movements from multicontact DBS leads in 27 hemispheres. Resting- and movement-state features from multiple frequency bands (alpha, low beta, high beta, gamma, fast gamma, high frequency oscillations [HFO]) were used to predict the clinical outcome parameters. Subanalyses included an anatomical stimulation sweet spot as an additional feature.
Results
Both resting- and movement-state features contributed to the prediction, with resting (fast) gamma activity, resting/ movement-modulated beta activity, and movement-modulated HFO being most predictive. With the proposed algorithm, the best stimulation contact for the three clinical outcome parameters can be identified with a probability of almost 90% after considering half of the DBS lead contacts, and it outperforms the use of beta activity as single marker. The combination of electrophysiological and imaging markers can further improve the prediction.
Conclusion
LFP-guided DBS programming based on algorithmic selection and combination of multiple electrophysiological and imaging markers can be an efficient approach to improve the clinical routine and outcome of DBS patients.
Keywords: DBS programming, deep brain stimulation, local field potentials, Parkinson disease, subthalamic nucleus
Introduction
Detailed testing of deep brain stimulation (DBS) electrodes is an essential step for maximizing the outcome of DBS.1,2 However, this contact review is time-consuming, requires highly trained human resources, and is often exhausting for the patients who have to endure numerous evaluations.3 This limitation is even more evident for multicontact segmented DBS leads,4,5 which, because of the increased number of contacts and myriad of possible contact combinations, cannot be fully exploited using the current clinical approach.6,7 More objective, smart, and data-driven programming strategies are required to improve this aspect of DBS therapy.
A promising approach to inform DBS programming is by taking advantage of electrophysiological recordings from the implanted DBS lead. There is a large body of literature linking Parkinson disease (PD) symptoms to spectral features in basal ganglia signals, with exaggerated beta activity (13–30 Hz) being the best characterized. The latter is suggested to exhibit a limiting effect on the information coding capacity within the motor circuitry8 and thereby provoking bradykinesia and rigidity symptoms.9–11 Previous work by us and other groups demonstrated feasibility in using subthalamic nucleus (STN) beta activity at rest to inform DBS programming for ring contacts12,13 and segmented contacts.14–16 However, there are other potentially informative features, such as movement-related desynchronization of beta activity, which is associated with improved motor performance and localizes to the motor STN.17–20Gamma activity (60–100 Hz) synchronizes with movement, is viewed as prokinetic signal, and is also evident in the dorsal STN.21–23 High frequency oscillations (HFO) are similarly modulated as gamma activity, with the modulation being negatively correlated to brady-kinesia scores.24,25 In contrast, lower frequencies such as alpha activity (8–12 Hz) are more prevalent in the ventral STN13 and have been associated with nonmotor features.26–28
Overall, multiple spectral features at rest and movement as well as imaging markers could all be putative indicators of the optimal stimulation site. Following this, the current work aims to illustrate the benefit of an algorithmic selection and combination of multiple features to predict three relevant clinical DBS measurements (clinical efficacy, therapeutic window, and side-effect threshold) to optimize DBS programming.
Materials and Methods
Patients and Surgery
In this study, we screened consecutive PD patients who under-went awake DBS surgery at the University Hospital in Bern from September 2017 to September 2019. The inclusion criteria were the following: 1) signed general consent (study approved by local ethics committee, 2017-00551); 2) local field potentials (LFPs) recorded at rest and during repetitive upper limb movements; 3) available systematic postoperative monopolar contact review of all stimulation contacts; and 4) two or more points in the contralateral upper limb rigidity score at baseline (off medication, off stimulation) during the postoperative clinical evaluation. After applying these criteria, a total of 27 hemispheres from 17 PD patients (11 male, 6 female), with a mean age at surgery of 58.6 ± 3.1 years and disease duration of 9.2 ± 1.2 years, were included (details in Supplementary Data Table S1). Patients were implanted with the Boston Vercise Cartesia directional leads (Boston Scientific, Marl-borough, MA) (Fig. 1a).
Local Field Potential Recording and Intraoperative Assessment
LFPs were recorded during awake DBS surgery from all eight contacts simultaneously after the lead was placed in its final position and fixed to the skull. Recordings were performed with a TMSi-Porti amplifier (Twente Medical Systems International, Oldenzaal, The Netherlands), using a sampling frequency of 2048 Hz and common average referencing. In a first step, we performed LFP recording at rest (mean duration: 101.3 seconds ± 6.4 seconds). In a second step, patients were asked to perform contralateral upper limb movements that consisted of hand closing and opening. Surface electromyography electrodes and accelerometers were placed on the upper limb to objectively detect the movement onset. Each single movement was prompted by a verbal "go" command recorded with a microphone, and each movement was separated by an interval of 7.5 seconds ± 0.25 seconds (range: 6.1-11.3 seconds). This was to ensure that the movement-related rebound did not compromise the following trial.29 We aimed to record 20 such movement trials; the precise number was allowed to vary because of the intra-operative setting and associated constraints.
Signal Processing
The raw signal of both rest and movement recordings was down-sampled to 1024 Hz and high-pass filtered at 5 Hz, and notch filters were set at 50 Hz and its harmonics (up to 400 Hz). For hemisphere 10, one directional contact and for hemisphere 22, one directional and one ring contact had to be excluded from the analysis because of signal saturation. To avoid biasing the feature selection (indicated subsequently in the text) because of potential differences in recorded voltage following different biophysical properties of the contacts or variability in impedances and hence, to maintain a comparable spectral distribution, the raw data was z-scored for each contact separately. Following this, the frequency decomposition was performed at 1 Hz resolution using the Wavelet method (ft_specest_wavelet script in FieldTrip—Morlet Wavelet, width = 12, gwidth = 5; Donders Institute for Brain, Cognition and Behaviour, 2010).
For the movement task, the continuous signal was segmented into four-second blocks centered around the movement onset. Trials containing signal artifacts (ie, owing to cable movement) were removed, leaving an average number of 17.4 ± 0.7 (range: 9–22) per hemisphere. The movement-related power modulation was estimated by normalizing the period from movement onset to 300 milliseconds after movement of each trial with respect to the baseline power averaged in a precue window ranging from –2 seconds to –1.5 seconds before movement and across trials. The movement-related modulation, which showed an event-related desynchronization (ERD) around the beta band and an event-related synchronization (ERS) around the gamma band, was then averaged across trials. For both resting and movement state, the following frequency bands were extracted for further analyses: alpha (8:12 Hz), low beta (13:20 Hz), high beta (21:30 Hz), gamma (60:90 Hz), fast gamma (105:145 Hz), and HFO (205:395 Hz). Figure 1b depicts an example with normalized features, and Supplementary Data Figure S1 illustrates the resting and movement spectral curves of the 12 electrophysiological features used.
Spatial-Electrophysiological Processing
In subanalyses, we reevaluated the contact prediction performance after adding an anatomical landmark to the feature list. As anatomical landmark feature, we set the minimum distance (Euclidean distance) of the contact center to a previously published volume of tissue activated (VTA)-based anatomical reference point (stimulation sweet spot indicating a low effect threshold) within the normalized space of the motor STN (Montreal Neurological Institute x: 12.5838 y: –12.4868 z: –6.2879).30 Lead reconstruction was performed with the Lead-DBS toolbox31,32 (details in the Supplementary Material).
Postoperative Clinical Assessment and Clinical Outcome Parameter
The postoperative monopolar contact review served as the main clinical outcome parameter to determine the value of LFPs to predict the optimal stimulation contacts. This assessment took place after 5.4 months (range 4–10 months) postoperatively to avoid major DBS stun effects33 and was performed by the DBS-team, blinded to LFP data. Clinical contact testing of each segmented ring level and all directional contacts followed the standardized monopolar contact review procedures2 after dopaminergic medication was withdrawn at least 12 hours and dopamine agonists up to 48 hours before testing. Clinical assessment focused on upper limb rigidity testing. First, the effect threshold (ET) was determined as the stimulation current necessary to completely relieve rigidity or to obtain the best achievable improvement. The side-effect threshold (ST) was defined as the stimulation current where limiting side effects occurred. Both ET and ST were determined by 0.5 mA incremental steps. Stimulation frequency and pulse width were set to 130 Hz and 60 μs by default. Therapeutic window (TW) was defined as the difference between ST and ET. DBS clinical efficacy was defined according to the following formula:
Only hemispheres with at least two points in Movement Disorder Society Unified Parkinson's Disease Rating Scale–assessed upper limb rigidity at baseline (off stimulation/medication) were used, to increase the dynamic range of the clinical response.
In addition to the postoperative clinical assessment at 5.4 months, we assessed the stimulation setting used at around one year after operation (12.5 months, range 11–15 months) for further comparisons.
Features Selection, Contact Prediction, and Statistical Analyses
All statistical analyses were performed using MATLAB (2019b; Mathworks, Natick, MA). To study the contact prediction accuracy, a two-step contact prediction method was implemented.
Step one includes the weighting and ranking of 12 electro-physiological features based on a Lasso regression with fivefold cross-validation performed on 66.7% of the data set (18/27 hemispheres). Step two uses previously developed prediction logic to predict cumulative probability of choosing the best contact on the remaining 33.3% of the data set (9/27 hemispheres). The inputs for step one (Lasso regression) are the 12 spectral features extracted from the LFP recordings as variables and the three clinical features (CE, TW, and ST) as the outcome measures, normalized (z-scored) within-feature category and hemisphere. The output of step one is a list of ranked spectral features and their corresponding weights to predict the best CE, TW, and ST.
Step two corresponds to a previously published prediction logic, where the contacts are ranked (from presumed best LFP-contact to worst LFP-contact) using the weights of five of the best spectral features (output of step one). The algorithm iterates through the LFP-based contact ranking and determines how many contacts need to be tested before the one with the best clinical metric (CE, TW, or ST) is identified. This is done individually for nine of the 27 hemispheres. The output of this stage is the relative number of hemispheres (in percent) for the incrementing number of contacts to be tested (from one to maximum) to determine the best clinical contact. This is termed as "likelihood" of predicting the optimal stimulation contact.
To increase the generalizability, this two-step method was repeated for 100 iterations, with random allocation of the hemispheres during each iteration to either the training (66.7%) data set or testing (33.3%, hold-out) data set. Consequently, we report the maximum, average, and minimum likelihoods of predicting the optimal stimulation contact using different feature combinations over these iterations. We would like to highlight that the over-arching goal of this work was to identify the optimal simulation contact and not to predict the clinical metric values (as a continuous measure). The pipeline is illustrated in Figure 1c and further detailed in the Supplementary Material section.
It should be noted that this two-step method was performed twice independently, once for the six centered segmented contacts only (referred to in the text as "segmented contacts") as input and once for all eight contacts (six segmented contacts + two ring contacts, referred to in the text as "all contacts") as input. Correspondingly, two sets of results are described for 1) segmented contacts and 2) all contacts. This distinction was made because segmented and ring contacts might differ in their biophysical properties, location, spatial resolution, and clinical response to stimulation. Given that the implantation strategy of DBS electrodes, as well as the programming strategy in terms of omnidirectional/directional stimulation, might vary from one to another DBS center, we are presenting the contact prediction accuracy for both electrode subsets.
Statistical tests used are explicitly outlined (Friedmann test for repeated measurements and one-sampled t-tests for single comparison). p Values were corrected for multiple comparisons using false discovery rate.
Results
Spectral Features and Clinical Relationship
Figure 2 illustrates the bivariate correlative relationship within the DBS lead between the multiple LFP resting- and movement-state features with the three clinical outcome parameters (CE, TW, and ST) for DBS programming. This is intended to provide a visual illustration of the overall trend between single spectral features and clinical parameters. For segmented contacts, CE correlates positively with rest low beta (13:20 Hz) and negatively with rest gamma (60:90 Hz), fast gamma (105:145 Hz), and HFO (205:395 Hz). For all contacts, only the resting state fast gamma is negatively correlated with CE. Similarly, for TW, considering segmented contacts, we see a negative correlation with resting state gamma and fast gamma. Considering all contacts, TW has a negative correlation with resting state fast gamma. Finally, the ST for segmented contacts has a negative correlation with resting gamma and movement-related HFO modulation, whereas for all contacts, it is negatively correlated with resting gamma. Moreover, the within-feature correlation is weak, which mitigates against information redundancy of the features (Supplementary Data Fig. S2).
Feature Selection and Ranking
In the previous section, we demonstrated the averaged correlative trend between features and clinical DBS outcome parameters. However, to select and weight the best spectral features for the contact prediction, we implemented Lasso regression in our analytical pipeline. This method takes all apparently weak predictors and assesses the correlations of each predictor with the outcome of interest in combination with all the other predictors, and accordingly assigns weights to each predictor. In addition, Lasso regression can simultaneously aid in feature selection by forcing unimportant features to have a coefficient of zero (effectively "knocking" them out of the trained model). The resulting feature, ranking from high to low predictive value and separately for the different clinical parameters, is illustrated in Figure 3a for segmented contacts and Figure 3b for all contacts. The most predictive feature for CE for both segmented contacts and all contacts is resting-state fast gamma activity (negative correlation), followed by resting-state low beta activity (positive correlation). Similarly, for TW and segmented contacts, the most predictive features are resting-state gamma activity (negative correlation), and considering all contacts, the most predictive feature is resting-state fast gamma activity (negative correlation). The second most predictive feature for both configurations is high beta activity (positive correlation). In contrast, the ST is best explained by movement-state HFO (negative correlation) and gamma at rest (negative correlation) for segmented contacts. Movement-related modulation of low beta and HFO (both negative correlation) is most predictive for the ST for all contacts. The consistency of these findings is supported by similar weights and correlative directions of the features found in the Lasso regression as well as in the simple bivariate-within hemisphere-correlations (Fig. 2).
Contact Prediction Performance
The overall prediction performance following our prediction pipeline (Fig. 1c) is illustrated as maximum, average, and minimum likelihoods in identifying one of the best rated clinical contacts evaluated on the hold-out set of nine hemispheres. It should be noted that the ranking of the contacts is determined by the algorithmic selection and combination of up to five of the best weighted electrophysiological features. When the segmented contacts are considered (Fig. 4a), the probability of identifying the best stimulation site after including the first contact can reach up to 46% for CE, 48% for TW, and 45% for ST. If half of the contacts are included (three out of six), the predictive value can increase to 88% for CE, 85% for TW, and 86% for ST. For the entire DBS lead (Fig. 5a), the maximum probability of identifying the best stimulation site after considering the first contact is around 36 % for CE, 40% for TW, and 36% for ST. By including half of the contacts (four of the eight), the prediction increases to 83% for CE, 86% for TW, and 87% for ST. The prediction performance is clearly above the prediction by chance (current clinical practice). Moreover, by applying less stringent criteria (ie, upper 30 percentile of the clinical ranking) (Fig. 6), the prediction can further be improved, hereby approximating 100% after considering half of the contacts. In addition, Supplementary Data Figure S3 illustrates the clinical performance metric for the CE, TW, and ST of the highest ranked contact using the presented algorithmic approach, which is superior to a contact selected by chance.
Impact of Combining Multiple Features
The question arises whether the obtained prediction performance in Figures 4a and 5a is only a consequence of the regression-based selection of the single best feature or whether the hierarchical (high to low ranked) combination of multiple features (up to five features) further drives the prediction performance. To answer this, we calculated the percentage change in prediction performance relative to the use of the single highest ranked feature, after stepwise including up to a total of five features. Here, we illustrate two aspects: first, whether there is an incremental or decremental trend in prediction performance across stepwise adding of features (Friedmann test), and second, whether the different feature combinations are different from using a single best feature (one-sampled t-test). Figures 4b and 5b refer to the probability of prediction of half of the contacts to be tested (ie, 3/ 6 for segmented contacts and 4/8 for all contacts). In addition, Supplementary Data Figure S4 provides the % change in prediction using the whole contact range. Regarding segmented contacts (Fig. 4b) for CE, adding additional features leads to decrement in contact prediction (x2 (3) = 36.26, p ≤ 0.001), with all feature combinations performing less than the single best feature. However, despite the finding that using additional features is not further improving the prediction of CE in respect to the use of the single best feature, all feature combinations still allow the prediction of contacts with a clinical metric that outperforms the prediction by chance (Supplementary Data Fig. S3). In contrast, for both TW and ST, there is a significant incremental trend in the prediction performance (TW: x2(3) = 36.88,p ≤ 0.001;ST: x2 (3) = 28.94, p ≤ 0.001), with different feature combinations (TW: two, three, four, and five features; ST: three, four, five features) performing better up to 14.2% (TW, combination of five features) and 7.8% (ST, combination of five features) than the single best feature. Similarly, when all contacts are considered (Fig. 5b), there is again a negative trend for CE (x2 (3) = 53.94, p ≤ 0.001), which is significant for two, three, four, and five features. The prediction of TW again benefits from adding multiple features (x2(3) = 50.25, p ≤ 0.001), and the combination of two, three, four, and five features shows a significant difference relative to the use of a single feature. For ST, there is no significant incremental trend for using multiple features (x2 (3) = 5.19, p = 0.159); however, all feature combinations, two up to five, show a significant higher prediction performance than using a single feature. For both TWand ST, the prediction reaches maximum with the combination of four features (TW 14.3% increase, ST 7.4% increase).
Algorithmic Approach in Comparison to Beta Activity as Single Feature
As additional subanalyses, we evaluate to what extent the presented algorithmic approach can outperform low beta activity used as a single feature, which currently represents the single best validated symptom biomarker for PD (Fig. 7). The relative change of the prediction performance has been derived as change in the area under the curve for testing only one and up to three contacts out of six segmented contacts (Fig. 7a) as well as for testing one and up to four of all eight contacts (Fig. 7b). The maximum algorithmic prediction outperforms the use of beta activity as a single feature with a significant median percentage improvement for the first-choice contact (1/6: CE [117%] and TW [30%]; 1/8: CE [99%], TW [57%], and ST [25%]) and for half of the contacts (3/6: CE [46%] TW [15%], and ST [20%]; 4/8: CE [32%], TW [17%], and ST [21%]). The average algorithmic prediction outperforms the use of beta activity with a significant median percentage improvement for first the choice contact (1/6: CE [63%]; 1/8: CE [38%], and TW [14%]) and for half of the contacts (3/6: CE [20%]; 4/8: CE [5%]). Finally, the minimum prediction obtained by the algorithmic approach significantly outperforms beta activity as a single feature in the following situation, the first-choice contact (1/6 CE [17%]). In the remaining iterations, the algorithmic is equally- or underperforming beta activity used as a single feature. Moreover, Supplementary Data Figure S5 illustrates the entire contact prediction plot based on low beta activity.
Inference of Chronic Stimulation Setting
To study whether the contact prediction obtained with the current approach is still informative for the chronic stimulation setting, we repeated the analysis using the documented stimulation setting at 12.5 months (instead of 5.4 months) postoperatively. In this cohort, most patients have a ring mode-stimulation in chronic use, and the stimulation level is usually selected according to the most convenient TW. Thus, we investigated if the "best LFP contact," defined by the spectral features for TW, can indicate the chronic stimulation level in use. This shows that the best chronic level can be identified in 47.3% after including one contact and further increases to 78.1% after including two contacts (Supplementary Data Fig. S6), which are both beyond the prediction by chance.
Combining Electrophysiological Features With an Anatomical Stimulation Hotspot
To investigate whether LFP-based contact prediction can be refined through anatomical information, we included an anatomical reference point, sweet spot distance (SSD), into the feature pool of the algorithm (Fig. 1c). SSD is defined as the minimum distance of the contact's center to a previously published VTA-based anatomical reference point that indicates a low stimulation ET within the motor STN.30 This reference point has been validated on the ET, used to calculate both CE and TW; therefore, results are indicated for those two clinical parameters. The results show that adding this anatomical landmark as feature does not improve the prediction performance for the six segmented contacts (Fig. 8a; median: CE: −1.5, TW: −f3.48%). In contrast, when the entire DBS lead is considered (Fig. 8b), adding the anatomical landmark leads to an increase of the prediction (median: CE: 10,8%, TW 5.8%). Supplementary Data Figure S7 illustrates the entire contact prediction plot solely based on the anatomical hotspot.
Discussion
This study demonstrates the potential of algorithmic selection and combination of multimodal features to guide multicontact DBS programming. We derive four major findings from this work. First, LFPs directly recorded from the DBS lead can be used to predict the optimal stimulation contacts for different clinical DBS outcome parameters (CE, TW, ST), all with a similar prediction performance. Second, algorithmic selection and combination of resting and movement state spectral features have the potential to outperform the use of beta activity as single feature. Third, the LFP-based method can predict the chronically used stimulation setting. Fourth, combining electrophysiological features with anatomical markers can further refine the prediction of the optimal stimulation site.
LFP-based Programming
The clinical use of multicontact DBS leads is more complicated and time-consuming because of the myriad of contact-combination6 and the lack of supportive tools, which hinders the efficient exploitation of this technology.34 In this study, we demonstrate that LFPs recorded from the DBS target structure could effectively be used to short-list and select optimal stimulation contacts, which would allow the clinician to focus on fewer but more promising stimulation contacts to be used alone or in combination. Indeed, by considering just half of the best ranked stimulation contacts, the prediction accuracy can reach almost 90%, thereby saving half of the programming time. At the same time, this result illustrates that none of the features is 100% predictive; otherwise, maximum accuracy would be reached after considering the highest electrophysiological ranked contact. For the interpretation of our presented method, it is important to note that we aim to predict the best rated clinical contact, which, although being a strict definition, serves to approximate the performance of LFP-based contact prediction. However, for completeness, we have also investigated the value of our method when applying a more relaxed definition (ie, prediction of a contact that is among the top 30% of best contacts). This is because, in clinical practice, more than one contact can be sufficient (alone or in combination) to help control symptoms, and therefore, an algorithmic approach that can identify any contact among the relatively better contacts is still anticipated to be clinically relevant and useful. Promising is the finding that LFP-based programming could be a versatile practical tool because a high prediction performance is reached independently of whether the desired clinical outcome parameter is CE, TW, or SE or whether segmented or all (ring + segmented) contacts are considered. Thus, the data presented here can be informative for different lead implantation and programming routines applied in the different DBS centers. Moreover, the LFP-guided contact selection can predict the level used for chronic DBS at 12.5 months after surgery
Selection and Combination of Features
An important novelty of this work is the algorithmic selection and combination of multiple resting and movement state spectral features to inform about the optimal stimulation contacts. Of interest is the observation that contacts exhibiting less gamma power are more predictive for high clinical efficacy and broad TW. Gamma power is broadly seen as prokinetic, whereas resting beta activity is rather indicative for motor impairment such as bradykinesia and rigidity, and the current results extend this inverse functional relationship to the framework of DBS contact prediction. In addition to resting-state features, movement-state features such as beta ERD and HFO ERS also turned out to be informative for the ST. For beta ERD, we argue that movement-related modulation should generally be indicative for the motor area of the target structure,19 whereas a larger distance to this modulation hot spot could indicate the proximity to neighboring structures, which, if stimulated, can induce side effects. The path-ophysiological role of HFOs is less well understood, but like previous studies, we found a negative clinical-electrophysiological relationship.24,25
Previously, electrophysiology-based strategies to improve DBS programming mainly involved STN beta activity,12–15,20,35 and studies already showed very promising results with a varying degree in contact prediction performance. Although beta activity is one of the most predictive features, with the current algorithmic approach, the prediction performance can be substantially increased. It also revealed that for CE, the data-driven selection of a single feature already reaches the maximum prediction of the best stimulation contact in most cases and adding further features does not add value, whereas the prediction of TW or ST clearly benefits from the combination of multiple features. A partial explanation for this could be that both TW and ST are slightly more complex parameters depending on more clinical-anatomical properties than CE. To increase the robustness of contact prediction algorithms, as well as to refine the number and weights of predictive features, studies on larger data sets are necessary.
Alternative and Complementary Methods
Beyond the spectral features used in this work, there are other promising electrophysiological markers for DBS contact prediction on the horizon. Recently, attention has been drawn to evoked resonant neural activity (ERNA), which can localize in the dorsal subregion of the STN and even be measured during general anesthesia.36–38 Measuring ERNA requires a high recording sample rate and a particular stimulation/recording paradigm, and is currently limited to an intraoperative recording set-up. In the future, the electrophysiological assessment for contact site prediction should be performed in the postoperative state using novel neurostimulators with brain sensing capabilities,39 and such devices should optimally be adjusted to enable recording for the full spectral content, including HFO and evoked activities. This would allow for a more flexible functional-electrophysiological profiling in the chronically implanted patient without the limitation of the intraoperative stun-effect and time constraints.
Another commonly investigated and intuitive approach to detect the optimal stimulation site is based on imaging, particularly on VTA modeling.40 This can be used to establish probabilistic outcome maps by aggregating the VTAs in large patient populations, as well as being linked to the network level by integrating fiber tract activations.31,41–43In the current work, we demonstrate that already adding an anatomical landmark indexing a sweet spot in the dorsal motor region to the feature list can refine the prediction. This is clear when the optimal stimulation contact is predicted from the entire span of the DBS lead, but less so when only the six centered segmented contacts are considered. The difference in the anatomical-spatial extent and spatial resolution of the two contact groups might explain this finding and may also partially contribute to the differences in the ranking of features and prediction scores, whereas other factors giving rise to spectral differences still need to be investigated. Beyond contact selection, DBS programming involves tuning of other parameters such as stimulation amplitude, frequency, and pulse width. To predict the latter three parameters for individual patients based on LFPs is challenging because this would require investigating the electrophysiological response curves during systematic stimulation with a broad range of stimulation parameters, an endeavor that must be investigated in future work. Imaging-based methods could provide another promising avenue because stimulation parameters could be approximated by stimulation field modeling combined with functional anatomy. Although the exact biophysical properties of both electrophysiological and imaging methods still need to be investigated and better understood, the current work crystallizes the idea that the combination of spectral and imaging features can be a powerful tool to explain more of the variance in clinical DBS response and to better guide DBS programming in the future.
Limitation
The LFP-based contact prediction performance shown here could be underestimated because the algorithm used determines the likelihood of identifying the single best stimulation contact, whereas in clinical practice, the combination of contacts is often used to reach optimal symptom control. Also, the clinical assessment was limited to upper-limb rigidity testing, which is, however, the most sensitive and reliable clinical sign for systematic DBS programming and a good proxy for bradykinesia symptoms.2However, the optimal stimulation contact and parameters for controlling other motor symptoms such as tremor and gait or nonmotor symptoms can be different and would therefore need to be adjusted on a case-by-case basis. Future studies need to investigate electrophysiological and anatomical programming markers to guide the optimization according to individual symptom profiles.
Moreover, manual clinical contact testing is a subjective method, and noise in the assessment may only have led to degrading the apparent predictive value of LFPs. We also assumed that lead position and orientation did not change after placement, which is also supported by recent literature.44 Any such rotation, however, might again have rather diminished the prediction performance. To prevent the impact of voltage differences in the raw signal owing to different biophysical properties of the contacts or variability in impedances, our processing included the normalization (z-scoring) of the filtered raw signal. Overall, applying normalization improves the comparability of bio-signals; however, we cannot exclude that in single instances, normalization might have led to some spectral distortion and suboptimal representation of power values, which we have tried to minimize by high-pass filtering the data at 5 Hz before any normalization. We also acknowledge that in computational pipelines as used in this work, overfitting is a challenge, and several methodologic steps (such as regularization via Lasso, hold-out set for testing, etc) have therefore been implemented to minimize it. In addition, to ensure a unified input distribution, clinical and electrophysiological features were normalized within hemisphere and feature category before feeding into Lasso regression. There is now a need to externally validate the proposed method by using a separate independent population cohort, and a prospective study design would also be needed. Moreover, the LFP signal-to-noise ratio may have been reduced because of stun effects, which can be detected as the STN is traversed.45
Outlook and Conclusion
In conclusion, this study suggests that a data-driven selection and combination of movement- and resting-state features from LFPs can be informative to optimize DBS programming in PD. Future work of this kind should include larger patient cohorts to increase the robustness of features selection and to set the foundation for user-friendly programming algorithms. The recent introduction of neurostimulators with brain sensing capabilities will facilitate systematic and widespread LFP measurements across different DBS indications. Similar approaches can also be used to determine the optimal LFP recording sites for closed-loop DBS algorithms. Overall, there is little doubt that these and other digital solutions, likely in combination, will optimize the use of DBS in clinical practice in the future.
Supplementary Material
To access the supplementary material accompanying this article, visit the online version of Neuromodulation: Technology at the Neural Interface at www.neuromodulationjournal.org and at https://doi.org/10.1016/j.neurom.2022.01.017.
Source(s) of financial support
Gerd Tinkhauser received funding from the Swiss Parkinson Association, the Baasch-Medicus Foundation and the Swiss National Science Foundation (project number: PZ00P3_202166). Ashesh Shah was funded by a project grant from the Swiss Parkinson Association. Andreas Nowacki received funding from the Swiss Parkinson Association. Thuy-Anh Khoa Nguyen received funding from the Swiss National Science Foundation (project number 186142). Saed Khawaldeh received research funding from Inception Institute of Artificial Intelligence, the Islamic Development Bank, and Nuffield Department of Clinical Neurosciences. Flavie Torrecillos, Alek Pogosyan, Huiling Tan, and Peter Brown are funded by the Medical Research Council (United Kingdom).
Footnotes
Authorship Statements
Ashesh Shah and Gerd Tinkhauser conceptualized the study, performed the statistical analysis, and drafted the manuscript. Ashesh Shah, Syed Ahmar Shah, Saed Khawaldeh, and Gerd Tinkhauser conceptualized the contact prediction algorithm. Katrin Peterman, Ines Debove, Martin Lenard Lachenmayer, Joan Michelis, and Paul Krack acquired the clinical data. Katrin Peterman, Ines Debove, Martin Lenard Lachenmayer, Joan Michelis, Claudio Pollo, Paul Krack, Andreas Nowacki, and Gerd Tinkhauser acquired electrophysiological data. Thuy-Anh Khoa Nguyen, Paul Krack, and Andreas Nowacki performed imaging processing and lead localization. Andreas Nowacki and Gerd Tinkhauser provided funding for the study. All authors revised and approved the final version of the manuscript.
Conflict of Interest: Gerd Tinkhauser received reimbursement of traveling expenses to scientific meeting by Boston Scientific not relevant to the submitted work. Paul Krack reports research grants from the Swiss National Science Foundation, the Roger de Spoelberch Foundation, Bertarelli Foundation, Annemarie Opprecht Foundation, Parkinson Schweiz, the Michael J. Fox Foundation, Aleva Neurotherapeutics, and Boston Scientific, personal fees (paid for lecturing and travel expenses to scientific meetings reimbursement to employing institution) from Boston Scientific, Bial, and Zambon, all outside the submitted work. Martin Lenard Lachenmayer received reimbursement of traveling expenses to scientific meeting by Medtronic and Teva Pharmaceutical Industries not relevant to the submitted work. Claudio Pollo reports consultant fees from Boston and Abbott not relevant to the submitted work. Andreas Nowacki reports consultant fees from Medtronic not relevant to the submitted work. Ines Debove reports research and travel grant from Boston Scientific not relevant to the submitted work. Joan Michelis received speaker honoraria from Merz Pharma Schweiz and from Allergan AG Schweiz. He has a consultancy contract with Allergan AG Schweiz. The remaining authors report no conflict of interest.
References
- 1.Moro E, Poon YY, Lozano AM, Saint-Cyr JA, Lang AE. Subthalamic nucleus stimulation: improvements in outcome with reprogramming. Arch Neurol. 2006;63:1266–1272. doi: 10.1001/archneur.63.9.1266. [DOI] [PubMed] [Google Scholar]
- 2.Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease. Mov Disord. 2006;21(suppl 14):S284–S289. doi: 10.1002/mds.20961. [DOI] [PubMed] [Google Scholar]
- 3.Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord. 2002;17(suppl 3):S188–S197. doi: 10.1002/mds.10163. [DOI] [PubMed] [Google Scholar]
- 4.Pollo C, Kaelin-Lang A, Oertel MF, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain. 2014;137:2015–2026. doi: 10.1093/brain/awu102. [DOI] [PubMed] [Google Scholar]
- 5.Steigerwald F, Muller L, Johannes S, Matthies C, Volkmann J. Directional deep brain stimulation of the subthalamic nucleus: a pilot study using a novel neuro-stimulation device. Mov Disord. 2016;31:1240–1243. doi: 10.1002/mds.26669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ten Brinke TR, Odekerken VJJ, Dijk JM, van den Munckhof P, Schuurman PR, de Bie RMA. Directional deep brain stimulation: first experiences in centers across the globe. Brain Stimul. 2018;11:949–950. doi: 10.1016/j.brs.2018.04.008. [DOI] [PubMed] [Google Scholar]
- 7.Kuhn AA, Volkmann J. Innovations in deep brain stimulation methodology. Mov Disord. 2017;32:11–19. doi: 10.1002/mds.26703. [DOI] [PubMed] [Google Scholar]
- 8.Khawaldeh S, Tinkhauser G, Shah SA, et al. Subthalamic nucleus activity dynamics and limb movement prediction in Parkinson's disease. Brain. 2020;143:582–596. doi: 10.1093/brain/awz417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Neumann WJ, Degen K, Schneider GH, et al. Subthalamic synchronized oscillatory activity correlates with motor impairment in patients with Parkinson's disease. Mov Disord. 2016;31:1748–1751. doi: 10.1002/mds.26759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kuhn AA, Tsui A, Aziz T, et al. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol. 2009;215:380–387. doi: 10.1016/j.expneurol.2008.11.008. [DOI] [PubMed] [Google Scholar]
- 11.Khawaldeh S, Tinkhauser G, Torrecillos F, et al. Balance between competing spectral states in subthalamic nucleus is linked to motor impairment in Parkinson's disease. Brain. doi: 10.1093/brain/awab264. Published online July 15, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yoshida F, Martinez-Torres I, Pogosyan A, et al. Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010;81:885–889. doi: 10.1136/jnnp.2009.190918. [DOI] [PubMed] [Google Scholar]
- 13.Zaidel A, Spivak A, Grieb B, Bergman H, Israel Z. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease. Brain. 2010;133:2007–2021. doi: 10.1093/brain/awq144. [DOI] [PubMed] [Google Scholar]
- 14.Tinkhauser G, Pogosyan A, Debove I, et al. Directional local field potentials: a tool to optimize deep brain stimulation. Mov Disord. 2018;33:159–164. doi: 10.1002/mds.27215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bour LJ, Lourens MA, Verhagen R, et al. Directional recording of subthalamic spectral power densities in Parkinson's disease and the effect of steering deep brain stimulation. Brain Stimul. 2015;8:730–741. doi: 10.1016/j.brs.2015.02.002. [DOI] [PubMed] [Google Scholar]
- 16.Fernandez-Garcia C, Foffani G, Dileone M, et al. Directional local field potential recordings for symptom-specific optimization of deep brain stimulation. Mov Disord. 2017;32:626–628. doi: 10.1002/mds.26949. [DOI] [PubMed] [Google Scholar]
- 17.Doyle LM, Kuhn AA, Hariz M, Kupsch A, Schneider GH, Brown P. Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease. Eur J Neurosci. 2005;21:1403–1412. doi: 10.1111/j.1460-9568.2005.03969.x. [DOI] [PubMed] [Google Scholar]
- 18.Devos D, Szurhaj W, Reyns N, et al. Predominance of the contralateral movement-related activity in the subthalamo-cortical loop. Clin Neurophysiol. 2006;117:2315–2327. doi: 10.1016/j.clinph.2006.06.719. [DOI] [PubMed] [Google Scholar]
- 19.Tinkhauser G, Shah SA, Fischer P, et al. Electrophysiological differences between upper and lower limb movements in the human subthalamic nucleus. Clin Neurophysiol. 2019;130:727–738. doi: 10.1016/j.clinph.2019.02.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nguyen TAK, Schupbach M, Mercanzini A, Dransart A, Pollo C. Directional local field potentials in the subthalamic nucleus during deep brain implantation of Parkinson's disease patients. Front Hum Neurosci. 2020;14:521282. doi: 10.3389/fnhum.2020.521282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cassidy M, Mazzone P, Oliviero A, et al. Movement-related changes in synchronization in the human basal ganglia. Brain. 2002;125:1235–1246. doi: 10.1093/brain/awf135. [DOI] [PubMed] [Google Scholar]
- 22.Lalo E, Thobois S, Sharott A, et al. Patterns of bidirectional communication between cortex and basal ganglia during movement in patients with Parkinson disease. J Neurosci. 2008;28:3008–3016. doi: 10.1523/JNEUROSCI.5295-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lofredi R, Neumann WJ, Bock A, et al. Dopamine-dependent scaling of subthalamic gamma bursts with movement velocity in patients with Parkinson's disease. Elife. 2018;7:e31895. doi: 10.7554/eLife.31895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lopez-Azcarate J, Tainta M, Rodriguez-Oroz MC, et al. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophys-iological mechanism in Parkinson's disease. J Neurosci. 2010;30:6667–6677. doi: 10.1523/JNEUROSCI.5459-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Johnson LA, Aman JE, Yu Y, et al. High-frequency oscillations in the pallidum: a pathophysiological biomarker in Parkinson's disease? Mov Disord. 2021;36:1332–1341. doi: 10.1002/mds.28566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rappel P, Grosberg S, Arkadir D, et al. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus. Mov Disord. 2020;35:337–343. doi: 10.1002/mds.27910. [DOI] [PubMed] [Google Scholar]
- 27.Huebl J, Schoenecker T, Siegert S, et al. Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease. Mov Disord. 2011;26:477–483. doi: 10.1002/mds.23515. [DOI] [PubMed] [Google Scholar]
- 28.Ricciardi L, Fischer P, Mostofi A, et al. Neurophysiological correlates of trait impulsivity in Parkinson's disease. Mov Disord. 2021;36:2126–2135. doi: 10.1002/mds.28625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Pfurtscheller G, Lopes da Silva FH. Event-related EEG/MEG synchronization and desynchronization: basic principles. Clin Neurophysiol. 1999;110:1842–1857. doi: 10.1016/s1388-2457(99)00141-8. [DOI] [PubMed] [Google Scholar]
- 30.Nguyen TAK, Djilas M, Nowacki A, et al. Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus. PLoS One. 2019;14:e0217985. doi: 10.1371/journal.pone.0217985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Horn A, Li N, Dembek TA, et al. Lead-DBS v2: Towards a comprehensive pipeline for deep brain stimulation imaging. Neuroimage. 2019;184:293–316. doi: 10.1016/j.neuroimage.2018.08.068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Levy JP, Nguyen TAK, Lachenmayer L, et al. Structure-function relationship of the posterior subthalamic area with directional deep brain stimulation for essential tremor. Neuroimage Clin. 2020;28:102486. doi: 10.1016/j.nicl.2020.102486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Mestre TA, Lang AE, Okun MS. Factors influencing the outcome of deep brain stimulation: placebo, nocebo, lessebo, and lesion effects. Mov Disord. 2016;31:290–296. doi: 10.1002/mds.26500. [DOI] [PubMed] [Google Scholar]
- 34.Krack P, Volkmann J, Tinkhauser G, Deuschl G. Deep brain stimulation in movement disorders: from experimental surgery to evidence-based therapy. Mov Disord. 2019;34:1795–1810. doi: 10.1002/mds.27860. [DOI] [PubMed] [Google Scholar]
- 35.Milosevic L, Scherer M, Cebi I, et al. Online mapping with the deep brain stimulation lead: a novel targeting tool in Parkinson's disease. Mov Disord. 2020;35:1574–1586. doi: 10.1002/mds.28093. [DOI] [PubMed] [Google Scholar]
- 36.Sinclair NC, McDermott HJ, Fallon JB, et al. Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity. Neurobiol Dis. 2019;130:104522. doi: 10.1016/j.nbd.2019.104522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Sinclair NC, McDermott HJ, Bulluss KJ, et al. Subthalamic nucleus deep brain stimulation evokes resonant neural activity. Ann Neurol. 2018;83:1027–1031. doi: 10.1002/ana.25234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wiest C, Tinkhauser G, Pogosyan A, et al. Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa. NeurobiolDis. 2021;152:105287. doi: 10.1016/j.nbd.2021.105287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Feldmann LK, Neumann WJ, Krause P, Lofredi R, Schneider GH, Kuhn AA. Sub-thalamic beta band suppression reflects effective neuromodulation in chronic recordings. Eur J Neurol. 2021;28:2372–2377. doi: 10.1111/ene.14801. [DOI] [PubMed] [Google Scholar]
- 40.Frankemolle AM, Wu J, Noecker AM, et al. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming. Brain. 2010;133:746–761. doi: 10.1093/brain/awp315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Akram H, Sotiropoulos SN, Jbabdi S, et al. Subthalamic deep brain stimulation sweet spots and hyperdirect cortical connectivity in Parkinson's disease. Neuro-image. 2017;158:332–345. doi: 10.1016/j.neuroimage.2017.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Nguyen TAK, Nowacki A, Debove I, et al. Directional stimulation of subthalamic nucleus sweet spot predicts clinical efficacy: proof of concept. Brain Stimul. 2019;12:1127–1134. doi: 10.1016/j.brs.2019.05.001. [DOI] [PubMed] [Google Scholar]
- 43.Horn A, Neumann WJ, Degen K, Schneider GH, Kuhn AA. Toward an electrophysiological "sweet spot" for deep brain stimulation in the subthalamic nucleus. Hum Brain Mapp. 2017;38:3377–3390. doi: 10.1002/hbm.23594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lange F, Steigerwald F, Engel D, et al. Longitudinal assessment of rotation angles after implantation of directional deep brain stimulation leads. Stereotact Funct Neurosurg. 2021;99:150–158. doi: 10.1159/000511202. [DOI] [PubMed] [Google Scholar]
- 45.Chen CC, Pogosyan A, Zrinzo LU, et al. Intra-operative recordings of local field potentials can help localize the subthalamic nucleus in Parkinson's disease surgery. Exp Neurol. 2006;198:214–221. doi: 10.1016/j.expneurol.2005.11.019. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.